Investors are always searching for stocks to invest in that will double or triple with very little downside. The same investors scour every list of stocks they can find looking for good stocks to buy now. This is why here at AimHighProfits we don’t just cover good penny stocks, but also Nasdaq and NYSE stocks under 5, especially stocks on the rise which appear to have good value in them at their current prices.
Two stocks under $4 that received upgrades from Wall Street analysts in the last 5 days, GLUU and SLTM, are looking like two top stocks to buy for the long-term.
Glu Mobile Inc. (NASDAQ: GLUU)
While iPad and Android fight for market share in the tablet market, iPhone and Galaxy fight, among others, for market share in the smartphone market, Glu Mobile Inc. (NASDAQ: GLUU) takes advantage of it all with some of the best games you can get for any of the new tech gadgets in the market.
GLUU closed Thursday, March 15th at 3.94, down -0.10 (-2.48%) on volume of 1,323,060. GLUU received analyst coverage last week by analysts at Canaccord Genuity. They set a “buy” rating and a $7.00 price target on the stock.
Subscribe today and get our next stock alert delivered to your inbox FREE.
GLUU Snap Shot:
Market Cap: 248.11M
Enterprise Value (Mar 16, 2012): 215.90M
Forward P/E (fye Dec 31, 2013): 20.74
PEG Ratio (5 yr expected): -0.69
Price/Sales (ttm): 3.75
Price/Book (mrq): 5.04
52-Week Change3: 7.65%
52-Week High (Jul 15, 2011): 6.10
52-Week Low (Oct 4, 2011): 1.80
50-Day Moving Average: 3.91 (1.36%)
200-Day Moving Average: 3.26 (20.98%)
Avg Vol (3 month): 1,568,090
Avg Vol (10 day): 1,282,540
Shares Outstanding: 62.97M
Float: 44.88M
% Held by Insiders: 27.48%
Shares Short (as of Feb 29, 2012): 6.58M
Short Ratio (as of Feb 29, 2012): 3.10
GLUU Most Recent Income Statement
Revenue (ttm): 66.18M
Revenue Per Share (ttm): 1.15
Qtrly Revenue Growth (yoy): -3.00%
Gross Profit (ttm): 42.81M
EBITDA (ttm): -12.07M
Net Income Avl to Common (ttm): -21.10M
Diluted EPS (ttm): -0.37
About Glu Mobile (NASDAQ: GLUU)
GLUU is a leading global developer and publisher of Social Mobile games for smartphone and tablet devices. GLUU’s unique technology platform enables its titles to be accessible to a broad audience of consumers all over the world – supporting iOS, Android, Windows Phone, Google Chrome and beyond. GLUU is focused on bringing the best in social, freemium, cross-platform mobile gaming experiences to the mass market.
Founded in 2001, GLUU is headquartered in San Francisco and has major offices in Kirkland, Washington, Brazil, Canada, China, Russia and the UK. Glu is focused on creating compelling original IP and also partners with leading entertainment brands including Activision, Atari, Caesar’s and Fox.
Solta Medical Inc. (NASDAQ: SLTM)
With over 8,000 systems installed worldwide since the aesthetic medicine has evolved from a niche market serving the very rich with vanity procedures, to an anti-aging movement supported by baby boomers, Solta Medical Inc. (NASDAQ: SLTM) is looking to be the leader in developing transformational aesthetic products, procedures and services.
SLTM closed Thursday at 3.04, up 0.13 (+4.47%) on volume of 154,037. SLTM was upgraded by analysts at Morgan Keegan on Monday from a “market perform” rating to an “outperform” rating. They now have a $3.75 price target on the stock, up previously from $3.50.
SLTM Snap Shot:
Market Cap: 185.84M
Enterprise Value (Mar 16, 2012): 192.82M
Forward P/E (fye Dec 31, 2013): 19.00
PEG Ratio (5 yr expected): -3.88
Price/Sales (ttm): 1.60
Price/Book (mrq): 1.47
52-Week Change: -1.94%
52-Week High (May 6, 2011): 3.69
52-Week Low (Aug 18, 2011): 1.15
50-Day Moving Average: 2.89 (5.72%)
200-Day Moving Average: 2.38 (27.93%)
Avg Vol (3 month): 242,636
Avg Vol (10 day): 226,125
Shares Outstanding: 61.13M
Float: 40.68M
% Held by Insiders: 37.83%
Shares Short (as of Feb 29, 2012)3: 1.71M
Short Ratio (as of Feb 29, 2012)3: 4.90
SLTM Most Recent Income Statement
Revenue (ttm): 115.98M
Revenue Per Share (ttm): 1.92
Qtrly Revenue Growth (yoy): 10.30%
Gross Profit (ttm): 69.53M
EBITDA (ttm): 412.67K
Net Income Avl to Common (ttm): -1.33M
Diluted EPS (ttm): -0.02
About Solta Medical Inc. (NASDAQ: SLTM)
SLTM design, develop, manufacture and market aesthetic energy devices to address a range of skin conditions brought on by the effects of aging, environmental factors or hormonal changes. SLTM products are patented and generally require FDA clearance and in Europe, the CE Mark prior to marketing.
The product technologies SLTM uses include RF energy, to heat and shrink collagen and tighten tissue while simultaneously cooling and protecting the surface of the skin; lasers for skin resurfacing and the treatment of actinic keratosis; intense pulsed light (“IPL”) for the treatment of mild to moderate acne and other dermatologic conditions; and high intensity ultrasound (“HIFU”) for the destruction of subcutaneous adipose tissue for the purpose of waist circumference reduction.
SLTM was incorporated in 1996 and received FDA clearance for our first Thermage RF system in 2002. Through a number of acquisitions, SLTM added:
- the Fraxel laser systems from Reliant Technologies in December 2008;
- the Isolaz (IPL) system from Aesthera Corporation in February 2010;
- the Claro (IPL) personal care acne treatment device from CLRS in October 2010, and
- the Liposonix system from our acquisition of Medicis Technologies Corporation in November 2011.
SLTM’s latest product introduction is the CLEAR + BRILLIANT laser system, for which they received FDA clearance in May 2011. In addition, FDA clearance for the second generation Liposonix system which they acquired from Medicis Pharmaceutical Corporation (“Medicis”) was received in October 2011.
ShareMAR
